A Multicenter Trial Evaluating the Efficacy of Cesamet for the Symptomatic Treatment of Pain in Patients With Multiple Sclerosis

Trial Profile

A Multicenter Trial Evaluating the Efficacy of Cesamet for the Symptomatic Treatment of Pain in Patients With Multiple Sclerosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Feb 2008

At a glance

  • Drugs Nabilone (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2008 Status change from in progress to completed, as reported by clinicaltrials.gov.
    • 07 Feb 2007 New trial investigators added.
    • 14 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top